Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Winkler

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Genome Biology|June 6, 2008
Complex responses to a diverse environmentMary Collins, David G Winkler, Lih-Ling Lin
Bone|July 23, 2004
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblastsMay Kung Sutherland, James C Geoghegan, Changpu Yu, et al.
Bone|September 30, 2004
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formationMay Kung Sutherland, James C Geoghegan, Changpu Yu, et al.
The Journal of Biological Chemistry|June 17, 2004
Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complexDavid G Winkler, Changpu Yu, James C Geoghegan, et al.
The Journal of Biological Chemistry|November 17, 2004
Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteinsDavid G Winkler, May S Kung Sutherland, Ethan Ojala, et al.
Frontiers in Immunology|July 18, 2017
The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and DifferentiationHonyin Chiu, Sharmila Mallya, Phuongthao Nguyen, et al.
The EMBO Journal|November 25, 2003
Osteocyte control of bone formation via sclerostin, a novel BMP antagonistDavid G Winkler, May Kung Sutherland, James C Geoghegan, et al.
Nature Communications|October 18, 2017
Regulation of T cell alloimmunity by PI3Kγ and PI3KδMayuko Uehara, Martina M McGrath, Shunsuke Ohori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-α production in a receptor for advanced glycation end product-dependent mannerBenfang Helen Ruan, Xin Li, Aaron R Winkler, et al.
Rheumatology (Oxford, England)|August 29, 2009
TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokinesJun Kuai, Bernard Gregory, Andrew Hill, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Genome Biology|June 6, 2008
Complex responses to a diverse environmentMary Collins, David G Winkler, Lih-Ling Lin
Bone|July 23, 2004
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblastsMay Kung Sutherland, James C Geoghegan, Changpu Yu, et al.
Bone|September 30, 2004
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formationMay Kung Sutherland, James C Geoghegan, Changpu Yu, et al.
The Journal of Biological Chemistry|June 17, 2004
Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complexDavid G Winkler, Changpu Yu, James C Geoghegan, et al.
The Journal of Biological Chemistry|November 17, 2004
Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteinsDavid G Winkler, May S Kung Sutherland, Ethan Ojala, et al.
Frontiers in Immunology|July 18, 2017
The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and DifferentiationHonyin Chiu, Sharmila Mallya, Phuongthao Nguyen, et al.
The EMBO Journal|November 25, 2003
Osteocyte control of bone formation via sclerostin, a novel BMP antagonistDavid G Winkler, May Kung Sutherland, James C Geoghegan, et al.
Nature Communications|October 18, 2017
Regulation of T cell alloimmunity by PI3Kγ and PI3KδMayuko Uehara, Martina M McGrath, Shunsuke Ohori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-α production in a receptor for advanced glycation end product-dependent mannerBenfang Helen Ruan, Xin Li, Aaron R Winkler, et al.
Rheumatology (Oxford, England)|August 29, 2009
TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokinesJun Kuai, Bernard Gregory, Andrew Hill, et al.
Pageof 2